| 10 | 20241017 | [Revised]Decision on Merger(소규모합병) | |
| 9 | 20241014 | Decision on Merger(소규모합병) | |
| 8 | 20240808 | Material Management Information related to Judgment of Investment(유선종양에 이환된 개에서 수술 후 적용하는 항암병용치료제 (Vaxleukin-15 inj.) 품목허가 승인) | |
| 7 | 20240522 | Advance notice for assignment of issue for abnormal rise | |
| 6 | 20240522 | Material Management Information related to Judgment of Investment(Study Results)(진행성 간세포암 환자에서 자연살해세포와 간동맥주입화학요법 병합치료의 임상 2a상 연구 결과) | |
| 5 | 20240423 | Material Management Information related to Judgment of Investment(진행성 췌장암 환자에서 자연살해세포와 mFOLFIRINOX 병합치료의 임상 2a상 연구 임상시험계획 신청 반려) | |
| 4 | 20240327 | Outcomes of Annual Meeting of Shareholders | |
| 3 | 20240315 | Submission of Audit Report | |
| 2 | 20240307 | Reporting reasons for holding general shareholders' meeting on the most concentrated date | |
| 1 | 20240214 | [Revised]Resolutions for Convocation of General Meeting of Shareholders | |
